LOADING
Comparing Johnson & Johnson (JNJ) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | INTC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $630.8B |
| P/E Ratio | -- | -- |
| Forward P/E | -- | 63.3 |
| PEG Ratio | -- | 0.50 |
| EPS | -- | $-2.09 |
| Revenue Growth (YoY) | -- | 25.4% |
| Profit Margin | -- | -19.8% |
| Return on Equity | -- | -10.7% |
| Dividend Yield | -- | -- |
| Beta | -- | 2.23 |
| 52-Week High | -- | $142.35 |
| 52-Week Low | -- | $32.89 |
| Volume | -- | -- |